Study of the effect of anaesthesia on the canine ultrasonographic optic nerve sheath diameter

OBJECTIVES

To investigate the effects of anaesthetic duration and serial anaesthetic events on optic nerve sheath diameter in a population of dogs without intracranial disease using point-of-care ultrasonography.

MATERIALS AND METHODS

Client-owned dogs requiring advanced head imaging were prospectively enrolled. Exclusion criteria included signs of elevated intracranial pressure, glaucoma and optic nerve disease. Using a transpalpebral technique, two optic nerve sheath diameter measurements were recorded for each eye at three timepoints: following premedication, after induction within 7 minutes and before discontinuing isoflurane. Mixed model analysis was used to characterise optic nerve sheath diameter behaviour and investigate the effects of anaesthetic duration, bodyweight and anaesthetic protocol, age and sex.

RESULTS

Fourteen dogs of various ages, breeds and bodyweights were enrolled. A positive linear relationship was detected between body weight and optic nerve sheath diameter. In 12 of 14 dogs, the optic nerve sheath diameter increased from measurements taken after premedication when compared to measurements taken after induction within 7 minutes. In a subset of patients, measurements subsequently decreased when anaesthetic duration exceeded 120 minutes. Age, side, sex, final body temperature, blood pressure and anaesthetic protocol did not significantly affect optic nerve sheath diameter. No significant association was noted between optic nerve sheath diameter and end-tidal carbon dioxide after induction and before discontinuing isoflurane.

CLINICAL SIGNIFICANCE

When using point-of-care ultrasound, a transient increase in optic nerve sheath diameter occurs between premedication and within 7 minutes following induction, regardless of bodyweight. This should be taken into consideration when serial monitoring is performed.

Sevoflurane sedation attenuates early cerebral oedema formation through stabilisation of the adherens junction protein beta catenin in a model of subarachnoid haemorrhage: A randomised animal study

BACKGROUND

Severe neurological impairment is a problem after subarachnoid haemorrhage (SAH). Although volatile anaesthetics, such as sevoflurane, have demonstrated protective properties in many organs, their use in cerebral injury is controversial. Cerebral vasodilation may lead to increased intracranial pressure (ICP), but at the same time volatile anaesthetics are known to stabilise the SAH-injured endothelial barrier.

OBJECTIVE

To test the effect of sevoflurane on ICP and blood-brain barrier function.

DESIGN

Randomised study.

PARTICIPANTS

One hundred male Wistar rats included, 96 analysed.

INTERVENTIONS

SAH was induced by the endoluminal filament method under ketamine/xylazine anaesthesia. Fifteen minutes after sham surgery or induction of SAH, adult male Wistar rats were randomised to 4 h sedation with either propofol or sevoflurane.

MAIN OUTCOME MEASURES

Mean arterial pressure (MAP), ICP, extravasation of water (small), Evan's blue (intermediate) and IgG (large molecule) were measured. Zonula occludens-1 (ZO-1) and beta-catenin (β-catenin), as important representatives of tight and adherens junction proteins, were determined by western blot.

RESULTS

Propofol and sevoflurane sedation did not affect MAP or ICP in SAH animals. Extravasation of small molecules was higher in SAH-propofol compared with SAH-sevoflurane animals (79.1 ± 0.9 vs. 78.0 ± 0.7%, P = 0.04). For intermediate and large molecules, no difference was detected (P = 0.6 and P = 0.2). Both membrane and cytosolic fractions of ZO-1 as well as membrane β-catenin remained unaffected by the injury and type of sedation. Decreased cytosolic fraction of β-catenin in propofol-SAH animals (59 ± 15%) was found to reach values of sham animals (100%) in the presence of sevoflurane in SAH animals (89 ± 21%; P = 0.04).

CONCLUSION

This experiment demonstrates that low-dose short-term sevoflurane sedation after SAH in vivo did not affect ICP and MAP and at the same time may attenuate early brain oedema formation, potentially by preserving adherens junctions.

TRIAL REGISTRATION

No 115/2014 Veterinäramt Zürich.

Multivariable analysis of anesthetic factors associated with time to extubation in dogs

The purpose of this study was to identify factors that prolong the time to extubation in dogs. Anesthetic records of 900 dogs at a university teaching hospital were searched. Multiple linear regression was used to compare independent predictors (patient demographics, anesthetic and intraoperative variables) with the dependent variable (time to extubation). Induction with propofol (P < 0.025) was associated with a shorter time to extubation, while premedication with acepromazine (P = 0.000) was associated with a longer time to extubation. Time to extubation was increased by 0.311 minutes for every kilogram increase in body weight (P = 0.000), 5.924 minutes for every 1 °C loss in body temperature (P = 0.0000), and by 0.096 minutes for every 1 minute increase in anesthetic duration (P = 0.000). Anesthetic variables, which can be manipulated by the anesthetist, include choice of premedication and induction drugs, hypothermia, and duration of anesthesia.